SEC Form 4 · accession 0001562180-18-000497
GENTEX CORP · GNTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Mulder
Director
Period of report
Jan 29, 2018
Accepted (ET)
Jan 31, 2018 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000355811
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2018 | M | 12,000 | $15.855 | A | 48,304 | D | |
| Common Stock | Jan 29, 2018 | M | 14,000 | $14.30 | A | 62,304 | D | |
| Common StockF1 | Jan 29, 2018 | S | 26,000 | $23.5131 | D | 36,304 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) | $15.855 | Jan 29, 2018 | M | 12,000 | D | Nov 12, 2011 | May 12, 2021 | Common Stock | 12,000 | 0 | D |
| Employee Stock Option (Right to buy) | $14.30 | Jan 29, 2018 | M | 14,000 | D | Nov 15, 2014 | May 15, 2024 | Common Stock | 14,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $23.38 to $23.62. The price reported above reflects the weighted average price.